|Lyme bacteria found to hide in lymph nodes while US state mandates long-term antibiotics for chronic Lyme|
|Written by Matthew Hogg|
|Thursday, 23 June 2011 13:11|
Now, a team of researchers from University of California Davis has uncovered a mechanism by which B. burgdoferi can cleverly avoid being eliminated by the host's immune system. Ironically it apparently does so by migrating to lymph nodes where there are high concentrations of immune cells which one would logically assume would take care of the invading pathogen in no time, but this does not appear to be the case.
In experiments on mice the researchers found that B. burgdoferi quickly accumulated in the lymph nodes where they triggered a rapid and strong immune response centred around the proliferation of B lymphocytes and their differentiation into plasma cells. Experimentation showed that these plasma cells produced antibodies (predominantly IgM) specific to B. burgdoferi and were therefore capable of recognising and targeting the pathogen. The key finding however, was that the antibodies produced were of poor quality and lacked the potency to be able to clear the B. burgdoferi spirochete infection from the lymph nodes.
The scientists wrote in the journal PLoS Pathogens: "We hypothesize that by moving into the lymph node, usually a site in which strong immune responses are induced, Borrelia evades the immune response: it goes to the lymph nodes and tricks the immune system into making a very strong but inadequate response."
If the identified mechanism of immune evasion by accumulation in the lymph nodes occurs in humans as it did in the mice in this study, it would suggest that B. burgdoferi can indeed cause chronic infection and chronic Lyme disease. A chronic activation of a B cell-mediated immune response could account for many of the symptoms that have been linked to chronic Lyme disease.
In other news directly related to this research the state of New Hampshire has passed a bill into law that allows doctors to treat Lyme disease patients with long-term antibiotics without fearing for their medical licenses. The use of long-term antibiotics is frequently recommended by those physicians who see Lyme disease as a potentially chronic illness.
The bill's prime sponsor Gary Daniels, said the bill is an important step in helping both patients and doctors as it acknowledges chronic Lyme disease is a real ailment.
The bill states that: "No licensee may be subject to disciplinary action solely for prescribing, administering, or dispensing long-term antibiotic therapy for a patient clinically diagnosed with Lyme disease, if diagnosis and treatment has been documented and monitored in the physician's medical record for that patient."
Daniels said: "The problem we were encountering, and it seems to be a nationwide trend, is there are two standards for treatment and there seems to be favoritism over one standard that basically says there's no such thing as chronic Lyme disease."
He added that typically, if people have Lyme disease for longer than the four weeks traditionally thought to be the typical duration, they're instead treated for other diseases such as fibromyalgia or chronic fatigue syndrome.
"There can be such a thing as chronic Lyme disease and it can be treatable with long-term antibiotics. We're trying to set in place an environment where doctors are free to treat with long-term antibiotics and the bill says they can't be punished solely because they prescribe or administer long-term antibiotics," Daniels said.
Tunev SS Hastey CJ Hodzic E Feng S Barthold SW Baumgarth N (2011) Lymphoadenopathy during Lyme Borreliosis Is Caused by Spirochete Migration-Induced Specific B Cell Activation PLoS Pathology 7(5):e1002066
|Last Updated on Thursday, 23 June 2011 14:37|